The efficacy and safety profile of lisdexamfetamine dimesylate, a prodrug of d-amphetamine, for the treatment of attention-deficit/hyperactivity disorder in children and adults

Jadwiga Najib
  • Clinical Therapeutics, January 2009, Elsevier
  • DOI: 10.1016/j.clinthera.2009.01.015
The author haven't finished explaining this publicationThe author haven't finished explaining this publication
Read Publication

http://dx.doi.org/10.1016/j.clinthera.2009.01.015

The following have contributed to this page: Professor Jadwiga Najib